Patients should understand that expected weight loss varies by medication (approximately 5-10% with liraglutide, 10-15% with semaglutide, and potentially higher with tirzepatide), though responses in post-bariatric patients may differ from those in primary obesity treatment
Third, the TRIUMPH-4 population (obesity plus knee OA) is slightly different from the STEP-1 and SURMOUNT-1 populations (general obesity), so the definitive head-to-head comparison waits for TRIUMPH-1
Solo un profesional clnico autorizado puede recetar este medicamento para esta afeccin si, a su juicio clnico, su uso es mdicamente apropiado
103 Lower limb alignment, particularly the Q-angle (quadriceps angle), is also influential
This advanced formula features a liposomal delivery system that protects the glutathione through digestion and enhances absorption, making it more effective than standard supplements